Three Studies in Pediatric and Adult Patients Demonstrate that Tacrolimus Ointment is Safe and Effective in the Treatment of Atopic Dermatitis

Acta Dermatovenerologica Croatica

Volumn 11, Issue 2, 2003, Pages 131-132

  Lawrence, Ira ^a  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; PNEUMOCOCCUS VACCINE; TACROLIMUS;

ADOLESCENT; ADULT; ATOPIC DERMATITIS; CHILD; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NOTE; PRURITUS; SKIN ATROPHY;

EID: 0142246642     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. Tacrolimus ointment: Advancing the treatment of atopic dermatitis. J Am Acad Dermatol 2001;44:S1-72.
2. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000;136:999-1006.
3. Rico MJ, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. Allergy Asthma Proc 2002;23:191-7.
4. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Vereol Suppl (Stockh) 1989;144:637-44.